• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • OLINK Services
    • Biomarker Data Analyses
  • R&D
  • Products
    • NEUROLINCS
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
    • Your Customized Kit
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media

IN VITRO DIAGNOSTIC (IVD) ELISA KITS

Firalis provides colorimetric sandwich ELISA kits CE-marked (IVD) for use in human samples. Our validation process is compliant with the most stringent requirements of the ISO 17025 norm (GLPC compliant) ensuring our customers to use the most adapted and reliable tool for their analysis.

MMP-9 ELISA: Matrix Metalloproteinase-9
For in vitro diagnosis of risk of heart failure by quantification of MMP-9 protein in human EDTA plasma

Matrix Metelloproteinase-9 (MMP-9) is part of the matrix metalloproteinase family presenting a group of structurally related zinc-containing proteolytic enzymes. These enzymes play an important role in tissue remodeling of extracellular matrix. MMP-9 is a 92 kDa protein with a sequence length of 707 amino acids that is produced by epithelial cells and is stored in the secretory granules of neutrophils and eosinophils. It has been shown to mediate vascular leakage and to initiate the migration of inflammatory cells inducing wound repair.

IFU FiQuanti9 MMP-9 CE-IVD ELISA EN
IFU FiQuanti9 MMP-9 CE-IVD ELISA FR

* * * * *

NGAL ELISA: Neutrophil gelatinase-associated lipocalin
For in vitro diagnosis of heart failure by quantification of NGAL protein in human EDTA plasma

NGAL, a protein belonging to lipocalin family, plays an important role in vascular remodelling and plaque instability of atherosclerosis1,2. NGAL is found to be upregulated in cardiomyocytes in failing myocardium3. Plasma NGAL is a significant predictor of mortality and cardiovascular disease in community-dwelling older adults, independent of traditional risk factors and kidney function, and adds incremental value to NT-proBNP and CRP4.

IFU FiQuantiGal NGAL CE-IVD ELISA EN
IFU FiQuantiGal NGAL CE-IVD ELISA FR

Contact Firalis

Firalis Group

© Copyright 2020 all rights reserved. 

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE